| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |